Viewing StudyNCT00063713



Ignite Creation Date: 2024-05-05 @ 11:30 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00063713
Status: COMPLETED
Last Update Posted: 2008-02-11
First Post: 2003-07-02

Brief Title: VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Sponsor: Millennium Pharmaceuticals Inc
Organization: Millennium Pharmaceuticals Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-06
Start Date Type: None
Primary Completion Date: 2005-12
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2003-07-02
First Submit QC Date: July 3 2003
Study First Post Date: 2003-07-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2008-02-07
Last Update Post Date: 2008-02-11
Last Update Post Date Type: ESTIMATED